A study of the interactive effects of oral contraceptive use and dietary fat intake on blood pressure, cardiovascular reactivity and glucose tolerance in normotensive women

Journal of Hypertension

Volumn 16, Issue 3, 1998, Pages 357-368

  Straznicky, Nora E ^a,b   Barrington, Vicki E ^a   Branley, Pauline ^a   Louis, William J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b AUSTIN HEALTH   (Australia)

Author keywords

Ambulatory blood pressure; Dietary fat; Glucose tolerance; Oral contraceptives; Pressor response

Indexed keywords

ANGIOTENSIN; CHOLESTEROL; ETHINYLESTRADIOL PLUS LEVONORGESTREL; INSULIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NORADRENALIN; ORAL CONTRACEPTIVE AGENT; TRIACYLGLYCEROL;

ADULT; AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE MONITORING; CARBOHYDRATE METABOLISM; CARDIOVASCULAR RESPONSE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COLD PRESSOR TEST; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; FAT INTAKE; FEMALE; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; HEART RATE; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; LUTEAL PHASE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0031936043     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199816030-00013     Document Type: Article

References (57)

1. Task Force on Oral Contraceptives, World Health Organization. The WHO multicentre trial of the vasopressor effects of combined oral contraceptives: comparison with IUD. Contraception 1989; 40:129-145.
2. Fisch IR, Frank J. Oral contraceptives and blood pressure. JAMA 1977; 237:2499-2503.
3. Godsland IF, Crook D, Devenport M, Wynn V. Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease. Contraception 1995; 52:143-149.
4. Qifang S, Deliang L, Xiurong J, Haifang L, Zhongshu Z. Blood pressure changes and hormonal contraceptives. Contraception 1994; 50:131-141.
5. Nichols M, Robinson G, Bounds W, Newman B, Guillebaud J. Effect of four combined oral contraceptives on blood pressure in the pill-free interval. Contraception 1993; 47:367-376.
6. Heintz B, Schmauder C, Witte K, Breuer I, Baltzer K, Sieberth H et al. Blood pressure rhythm and endocrine functions in normotensive women on oral contraceptives. J Hypertens 1996; 14:333-339.
7. Cain MD, Walters WA, Catt KJ. Effects of oral contraceptive therapy on the renin - angiotensin system. J Clin Endocrinol 1971; 33:671-676.
8. Blum M, Zacharivich D, Gelernter I, Blum I. Influence of oral contraceptive treatment on blood pressure and 24-hour urinary catecholamine excretion in smoking as compared with non-smoking women. Adv Contracept 1988; 4:143-149.
9. Khaw K, Peart WS. Blood pressure and contraceptive use. BMJ 1982; 285:403-407.
10. Whitworth JA, Scoggins BA, Andrews J, Williamson PM, Brown MA. Haemodynamic and metabolic effects of short term administration of synthetic sex steroids in humans. Clin Exp Hypertens [A] 1992; 14:905-922.
11. Spellacy WN, Birk SA. The effect of intrauterine devices, oral contraceptives, oestrogens, and progestogens on blood pressure. Am J Obstet Gynecol 1972; 112:912-919.
12. Lehtovirta P. Haemodynamic effects of combined oestrogen/progestogen oral contraceptives. J Obstet Gynaecol Br Comm 1974; 81:517-525.
13. Emmons KM, Weidner G. The effects of cognitive and physical stress on cardiovascular reactivity among smokers and oral contraceptive users. Psychophysiology 1988; 25:166-171.
14. Davis MC, Matthews KA. Cigarette smoking and oral contraceptive use influence women's lipid, lipoprotein, and cardiovascular responses during stress. Health Psychology 1990; 9:717-736.
15. Manheim K, Hansson L, Milsom I, Pilhall M, Jern S. Oestrogen and progestogen modify the haemodynamic response to mental stress in young women. Acta Obstet Gynecol Scand 1996; 75:57-62.
16. Godsland IF, Crook D, Simpson R, Proudler T, Felton C, Lees B. et al. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. N Engl J Med 1990; 323:1375-1381.
17. Straznicky NE, Louis WJ, McGrade P, Howes LG. The effects of dietary lipid modification on blood pressure, cardiovascular reactivity and sympathetic activity in man. J Hypertens 1993; 11:427-437.
18. Straznicky NE, Howes LG, Barrington VE, Lam W, Louis WJ. Effects of dietary lipid modification on adrenoceptor-mediated cardiovascular responsiveness and baroreflex sensitivity in normotensive subjects. Blood Pressure 1997; 6:96-102.
19. Schwab US, Uusitupa MIJ, Karhapaa P, Rasanen M, Makinen ES, Laakso M. Positive effect of ω-6 polyunsaturated fatty acids on glucose tolerance in healthy subjects [abstract]. Diabetiologia 1992; 35 (suppl 1): A40.
20. Sumner DJ, Elliott HL, Vincent J, Reid JL. A pragmatic approach to the pressor dose-response as an index of vascular reactivity and adrenoceptor function. Br J Clin Pharmacol 1987; 23:505-510.
21. Bergman RN, Prager R, Volund A, Olefsky JM. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycaemic glucose clamp. J Clin Invest 1987; 79:790-800.
22. Uusitupa M, Schwab U, Makimattila S, Karhapaa P, Sarkkinen E, Maliranta H, et al. Effects of two high-fat diets with different fatty acid compositions on glucose and lipid metabolism in healthy young women. Am J Clin Nutr 1994; 59:1310-1316.
23. Sumner DJ, Elliott HL, Reid JL. Analysis of the pressor dose response. Clin Pharmacol Ther 1982; 32:450-458.
24. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18:499-502.
25. Straznicky NE, Howes LG, Lam W, Louis WJ. Effects of pravastatin on cardiovascular reactivity to norepinephrine and angiotensin II in patients with hypercholesterolaemia and systemic hypertension. Am J Cardiol 1995; 75:582-586
26. Howes LG, Miller S, Reid JL. Simultaneous assay of 3,4-dihydroxyphenylethylene glycol and norepinephrine in human plasma by high-performance liquid chromatography with electrochemical detection. J Chromatogr 1985; 338:401-403.
27. Sealey JE. Plasma renin activity and plasma prorenin assays. Clin Chem 1991; 37:1811-1819.
28. Daly LE, Bourke GJ, McGilvray J: Data presentation. In: Interpretation and uses of medical statistics. Oxford: Blackwell Science; 1995. pp. 14-15.
29. Bolton S. Experimental design in clinical trials. In: Swarbrick J (editor) Pharmaceutical statistics. Clinical and practical applications. New York: Marcel Dekker; 1984. pp. 312-321.
30. Burkman RT. Lipid and lipoprotein changes in relation to oral contraception and hormonal replacement therapy. Fertil Steril 1988; 49 (suppl):39S-50S.
31. Storlien LH, Pan DA, Kriketos AD, Baur LA. High fat diet-induced insulin resistance. Lessons and implications from animal studies. Ann NY Acad Sci 1993; 683:82-90.
32. Pelikanova T, Kohout M, Valek J, Base J, Kazdova L. Insulin secretion and insulin action related to the serum phospholipid fatty acid pattern in healthy men. Metabolism 1989; 38:188-192.
33. Borkman M, Storlien LH, Pan DA, Jenkins AB, Chisolm DJ, Campbell LV. The relationship between insulin sensitivity and the fatty acid composition of phospholipids of skeletal muscle. N Engl J Med 1993; 328:238-244.
34. Grunfeld C, Baird KL, Kahn RC. Maintenance of 3T3-L1 cells in culture media containing saturated fatty acids decreases insulin binding and insulin action. Biochem Biophys Res Commun 1981; 103:219-226.
35. Ginsberg BH, Jabour J, Spector AA. Effect of alterations in membrane lipid unsaturation on the properties of the insulin receptor of Ehrlich ascites cells. Biochim Biophys Acta 1982; 690:157-164.
36. Gillespy M, Notelovitz M, Ellingson AB, Khan FY. Effect of long-term triphasic oral contraceptive use on glucose tolerance and insulin secretion. Obstet Gynecol 1991; 78:108-114.
37. Walters WAW, Lim YL Haemodynamic changes in women taking oral contraceptives. J Obstet Gynaecol Br Comm 1970; 77: 1007-1012.
38. Lehtovirta P. Haemodynamic effects of combined oestrogen/progestogen oral contraceptives. J Obstet Gynaecol Br Comm 1974; 81:517-525.
39. Cain MD, Walters WA, Catt KJ. Effects of oral contraceptive therapy on the renin-angiotensin system. J Clin Endocrinol 1971; 33:671-676.
40. Colucci WS, Gimbrone MA, McLaughlin MK, Halpern W, Alexander RW. Increased vascular catecholamine sensitivity and α-adrenergic receptor affinity in female and oestrogen-treated male rats. Circ Res 1982; 50:805-811.
41. Hamlet MA, Rorie DK, Tyce GM. Effects of oestradiol on release and disposition of norepinephrine from nerve endings. Am J Physiol 1980; 239:H450-H456.
42. Klangkalya B, Chan A. The effects of ovarian hormones on beta-adrenergic and muscarinic receptors in rat heart. Life Sci 1988; 42:2307-2314.
43. Jiang C, Sarrel PM, Lindsay DC, Poole-Wilson PA, Collins P. Progesterone induces endothelium-independent relaxation of rabbit coronary artery in vitro. Eur J Pharmacol 1992; 211:163-167.
44. Belfort MA, Saade GR, Suresh M, Vedernikov Y. Effects of oestradiol-17β and progesterone on isolated human omental artery from premenopausal nonpregnant women and from normotensive and preeclamptic pregnant women. Am J Obstet Gynecol 1996; 174:246-253.
45. Omar HA, Ramirez R, Gibson M. Properties of a progesterone-induced relaxation in human placental arteries and veins. J Clin Endocrinol Metab 1995; 80:370-373.
46. Miller VM, Vanhoutte PM. Progesterone and modulation of endothelium-dependent responses in canine coronary arteries. Am J Physiol 1991; 261:R1022-R1027.
47. Giraud GD, Morton MJ, Wilson RA, Burry KA, Speroff L. Effects of oestrogen and progestin on aortic size and compliance in post-menopausal women. Am J Obstet Gynecol 1996; 174:1708-1718.
48. Wilson ESB, Cruickshank J, McMaster M, Weir RJ. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen. Br J Obstet Gynaecol 1984; 91:1254-1260.
49. Hall WD, Douglas MB, Blumstern BA, Hatcher RA. Blood pressure and oral progestational agents. A prospective study of 119 black women. Am J Obstet Gynecol 1980; 136:344-348.
50. Rosselli M, Imthurm B, Macas E, Keller PJ, Dubey RK. Circulating nitrate/nitrite levels increase with follicular development: indirect evidence for oestradiol mediated NO release. Biochem Biophys Res Commun 1994; 202:1543-1552.
51. Goldstein DS, Levinson P, Keiser HR. Plasma and urinary catecholamines during the human ovulatory cycle. Am J Obstet Gynecol 1983; 146:824-829.
52. Hoffman P, Mest HJ, Krause EG, Will-Shahab L. Investigations on the mechanism of a diminished inotropic isoprenaline effect in isolated rat hearts after high linoleic acid diet. Biomed Biochim Acta 1988; 47:881-886.
53. 3H]-dihydroalprenolol and adenylate cyclase activity in rat atria. J Pharmacol Exp Ther 1981; 219:625-631.
54. Adam O, Wolfram G. Effect of different linoleic acid intakes on prostaglandin biosynthesis and kidney function in man. Am J Clin Nutr 1984; 40:763-770.
55. Judd JT, Marshall MW, Dupont J. Relationship of dietary fat to plasma fatty acids, blood pressure and urinary eicosanoids in adult men. J Am Coll Nutr 1989; 8:386-399.
56. 2 in a controlled trial with a lacto-ovo-vegetarian diet. J Hypertens 1986; 4:241-250.
57. Sacks FM, Gerhard M, Walsh BW. Sex hormones, lipoproteins, and vascular reactivity. Curr Opin Lipidol 1995; 6:161-166.